IGC·45408X308·US·equity·Healthcare - Biotechnology
IGC (IGC PHARMA INC) is held by 17 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($274,440), BlackRock, Inc. ($185,099), RENAISSANCE TECHNOLOGIES LLC ($127,285). Net institutional sentiment: Mixed.
See how IGC's score breaks down across 4 SEC sources
No recent insider, activist, or congressional trades found for this stock
Showing 1-20 of 20
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer